The high-resolution melting analysis market is projected to grow with a CAGR of nearly 3.3% over the forecast period. The major factor attributing to the growth of the market is the increase in the incidence of genetic disorders and infectious diseases. According to World Health Organization (WHO), approximately 50,000 people are dying every day from infectious diseases and 30 new diseases have surfaced in the last 20 years and now together threaten the health of hundreds of millions of people. Furthermore, the growing usage of HRM (High Resolution Melting) in the identification of pathogens and the advantages of HRM over the other genotyping techniques is boosting the market growth. However, the technical limitations of the HRM analysis is the major drawback of the market growth.
Key Market Trends
HRM Instruments Segment is Expected to be the Largest Segment of HRM Analysis Market.
Growing application of HRM analysis for identification of candidate predisposition genes, DNA mapping, mutation discovery, and HLA typing are amongst the few factors that are expected to boost the segment growth. Furthermore increasing incidence of infectious diseases and genetic disorders, gaining popularity in personalized medicine and growing awareness regarding the limitations of conventional systems over HRM are other major factors driving the market growth.
The advantages of the HRM analysis over other genotyping methods are that it is cost-effective which makes it perfect for large scale genotyping projects. It is fast and effective thus, able to precisely genotype many samples rapidly. It is simple, with a good quality HRM assay, powerful genotyping can be achieved by non-geneticists in any laboratory with access to an HRM capable real-time PCR machine.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to the factors such as the presence of key players, high prevalence of genetic and infectious diseases in the region, and established healthcare infrastructure. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the factors that drivers the market growth. In this region the United States has the maximum share due to supportive healthcare policies, the high number of patients, and a developed healthcare market.
The High-Resolution Melting Analysis market is moderately competitive and consists of several major players. Some of the international companies which are present in the market are Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., F. Hoffman-La Roche Ltd., Qiagen N.V., Agilent Technologies, Inc., Idaho Technology, Inc., Illumina, Inc., Kapa Biosystems, Azura Genomics, Canon.
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1.2 Study Assumptions
1.3 Scope of the Study
4.2 Market Drivers
4.2.1 Rising Prevalence of Genetic Disorders and Infectious Diseases
4.2.2 Advantages of HRM Over Other Genotyping Technologies
4.2.3 Use of HRM in Pathogen Identification
4.3 Market Restraints
4.3.1 Technical Limitations Associated With HRM
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1.1 Reagents and Consumables
5.1.3 Software and Services
5.2 By Application
5.2.1 SNP Genotyping
5.2.2 Mutation Discovery
5.2.3 Pathogen Identification
5.3 By End-User
5.3.1 Research Laboratories and Academic Institutes
5.3.2 Pharmaceutical and Biotechnology Companies
5.4.1 North America
220.127.116.11 United States
18.104.22.168 United Kingdom
22.214.171.124 Rest of Europe
126.96.36.199 South Korea
188.8.131.52 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
184.108.40.206 South Africa
220.127.116.11 Rest of Middle-East and Africa
5.4.5 South America
18.104.22.168 Rest of South America
6.1.1 Thermo Fisher Scientific, Inc.
6.1.2 Bio-Rad Laboratories, Inc.
6.1.3 F. Hoffman-La Roche Ltd.
6.1.4 Qiagen N.V.
6.1.5 Agilent Technologies, Inc.
6.1.6 Idaho Technology, Inc.
6.1.7 Illumina, Inc.
6.1.8 Kapa Biosystems
6.1.9 Azura Genomics
A selection of companies mentioned in this report includes:
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffman-La Roche Ltd.
- Qiagen N.V.
- Agilent Technologies, Inc.
- Idaho Technology, Inc.
- Illumina, Inc.
- Kapa Biosystems
- Azura Genomics